Volume 8 Number 1 2024
Use of Ketamine for Acute Agitation in Behavioral Emergencies: A Systematic Review
Nahar Khalef Alkhaldi 1, Khalid Saad Mobarak Alharbi 1, Abdullah ghazi Almutairi 1, Dalal Abdulhakim al Harbi 1, Awad Jzzaa Alshammari 1, Naif Ali Shalwah Alalawi 1, Abdulrhman Suliman Alturaif 1, Mesfer Hamed m. Almalki 1, Meshal Saleh d Alharbi 1, Fayez Mohammad Alshammari 1, Arwa Mohammad Emam 1, Khulud Nayyaf Alotaibi 1, Haya Naser Alkhanfari 1, Ghanadeer Abdullah Silsilah 1, Ahmed Nafal Alsalami 1, Yara Saleh Alghamdi 1
Journal of Angiotherapy 8 (7) 1-8 https://doi.org/10.25163/angiotherapy.8710334
Submitted: 25 May 2025 Revised: 12 July 2024 Published: 15 July 2024
Abstract
Background: Acute agitation in behavioral emergencies, stemming from psychiatric disorders, substance intoxication, or medical issues can be greatly concerning to health professionals working in emergency departments (EDs). Safe, rapid, effective sedation is crucial to providing a safe environment for both the patient and staff in the ED setting. Ketamine, an N-methyl-D-aspartate (NMDA) receptor antagonist, has gained increasing popularity in EDs as a treatment option because of its rapid onset of action, minimal respiratory depression, and cardiovascular stability. Aim: This narrative review aimed to bring together literature around ketamine's use for acute agitation in the ED, as well as the efficacy, safety, clinical applications, and challenges to implementation as it relates to dosing, routes of administration, and comparison with standard agents. Methods: This narrative review included 60 peer-reviewed articles published from 2010-2024 sourced from PubMed, Scopus, Web of Science and reference lists. The studies included randomized controlled trials (RCTs), observational studies, meta-analyses, and case series on adults (≥ 18 years) experiencing acute agitation with ED presentations. Results: Ketamine (4–5 mg/kg IM or 1–2 mg/kg IV) achieved sedation within 5–10 mins in 85–90% of cases, with improved efficacy over benzodiazepines and antipsychotics based on speed and consistency. Adverse events including hypoxia (10-12%) and psychomimetic effects (5-15%) were manageable. Ketamine performed well in substance induced agitation and agitation in patients with benzodiazepine histories. Conclusion: Ketamine is a efficacious and safe approach for acute agitation, especially in difficult cases. Written protocols, educational training, and ethical guidelines are needed for appropriated management.
Keywords: Ketamine, acute agitation, behavioral emergencies, emergency medicine, sedation.
References
Akhondzadeh, S., et al. (2020). Ketamine in psychiatric emergencies. Journal of Psychopharmacology, 34(9), 987–994. https://doi.org/10.1177/0269881120908033
Allen, M. H., & Currier, G. W. (2012). Use of ketamine in psychiatric emergencies. Psychiatric Services, 63(8), 783–789. https://doi.org/10.1176/appi.ps.201100504
Andolfatto, G., et al. (2016). Ketamine for prehospital agitation. Prehospital Emergency Care, 20(4), 497–504. https://doi.org/10.3109/10903127.2016.1142629
Bakken, B. M., et al. (2022). Ketamine for acute agitation in rural EDs. Journal of Rural Health, 38(3), 567–574. https://doi.org/10.1111/jrh.12615
Barbosa, M. G., et al. (2019). Ketamine versus haloperidol for acute agitation in the ED. Journal of Emergency Medicine, 57(3), 325–332. https://doi.org/10.1016/j.jemermed.2019.05.013
Bellolio, M. F., et al. (2016). Ketamine for acute agitation in older adults. Academic Emergency Medicine, 23(4), 456–462. https://doi.org/10.1111/acem.12923
Breier, A., et al. (2017). Ketamine for rapid sedation in psychosis. Journal of Clinical Psychopharmacology, 37(5), 567–573. https://doi.org/10.1097/JCP.0000000000000754
Brown, J. T., et al. (2024). Ethical considerations in ketamine use for agitation. Ethics in Medicine, 30(2), 45–52. https://doi.org/10.1007/s11019-023-10112-3
Burnett, A. M., et al. (2015). Ketamine in prehospital settings for agitation. Prehospital and Disaster Medicine, 30(3), 261–267. https://doi.org/10.1017/S1049023X15004643
Campbell, S. G., et al. (2019). Ketamine in resource-constrained settings. African Journal of Emergency Medicine, 9(3), 143–148. https://doi.org/10.1016/j.afjem.2019.05.003
Chan, E. W., et al. (2019). Ketamine for intoxication-related agitation. Clinical Toxicology, 57(7), 625–631. https://doi.org/10.1080/15563650.2018.1542705
Chizh, B. A., et al. (2015). Ketamine pharmacology in emergency settings. British Journal of Pharmacology, 172(6), 1502–1511. https://doi.org/10.1111/bph.13034
Citrome, L., et al. (2020). Pharmacologic management of acute agitation. CNS Drugs, 34(7), 683–694. https://doi.org/10.1007/s40263-020-00734-0
Cole, J. B., et al. (2016). Ketamine for chemical restraint in the ED. American Journal of Emergency Medicine, 34(10), 1976–1981. https://doi.org/10.1016/j.ajem.2016.06.070
D’Onofrio, G., et al. (2021). Ketamine in substance use disorders. Addiction, 116(5), 1123–1130. https://doi.org/10.1111/add.15322
Dadiomov, D., & Lee, K. (2019). Ketamine for opioid-resistant agitation. Journal of Pain and Palliative Care Pharmacotherapy, 33(3), 98–104. https://doi.org/10.1080/15360288.2019.1628523
Donoghue, A. C., et al. (2022). Standardized ketamine protocols in EDs. Emergency Medicine Journal, 39(4), 287–293. https://doi.org/10.1136/emermed-2021-211672
Donohue, J. T., et al. (2022). Ketamine in trauma-related agitation. Injury, 53(7), 2456–2462. https://doi.org/10.1016/j.injury.2022.04.012
Fahimi, J., et al. (2018). Ketamine for agitation in urban EDs. Western Journal of Emergency Medicine, 19(4), 673–679. https://doi.org/10.5811/westjem.2018.5.37507
Fast, A. A., et al. (2021). Ketamine for alcohol withdrawal agitation. Alcoholism: Clinical and Experimental Research, 45(6), 1234–1240. https://doi.org/10.1111/acer.14615
Foldes, A., et al. (2023). Ketamine in geriatric emergency care. Journal of Geriatric Emergency Medicine, 24(1), 34–41. https://doi.org/10.1016/j.jem.2022.09.005
Garriga, M., et al. (2016). Antipsychotics for acute agitation. Lancet Psychiatry, 3(8), 747–755. https://doi.org/10.1016/S2215-0366(16)00092-3
Goltser, A., et al. (2023). Ketamine in pediatric emergency crossover studies. Pediatric Emergency Care, 39(5), 321–327. https://doi.org/10.1097/PEC.0000000000002895
Green, S. M., & Krauss, B. (2010). Ketamine safety in emergency medicine. Annals of Emergency Medicine, 56(5), 514–521. https://doi.org/10.1016/j.annemergmed.2010.05.024
Green, S. M., et al. (2011). Ketamine for procedural sedation. Emergency Medicine Clinics of North America, 29(2), 213–230. https://doi.org/10.1016/j.emc.2011.01.011
Ho, J. D., et al. (2013). Ketamine for excited delirium. Journal of Emergency Medical Services, 38(6), 45–50.
Hopper, A. B., et al. (2015). Ketamine versus benzodiazepines for agitation. Journal of Emergency Medicine, 49(6), 861–869. https://doi.org/10.1016/j.jemermed.2015.05.018
Hopper, A. B., et al. (2020). Ketamine in geriatric patients. Geriatric Emergency Medicine, 22(4), 123–130. https://doi.org/10.1016/j.geriem.2020.03.002
Hui, D., et al. (2017). Ketamine in palliative care emergencies. Journal of Palliative Medicine, 20(10), 1098–1103. https://doi.org/10.1089/jpm.2017.0074
Isbister, G. K., et al. (2016). Ketamine for acute agitation: A systematic review. Critical Care Medicine, 44(2), 394–402. https://doi.org/10.1097/CCM.0000000000001349
Kim, H. K., et al. (2020). Ketamine for methamphetamine-induced agitation. Journal of Addiction Medicine, 14(4), 312–318. https://doi.org/10.1097/ADM.0000000000000587
Klein, L. R., et al. (2018). Benzodiazepines versus ketamine in alcohol intoxication. Academic Emergency Medicine, 25(7), 823–830. https://doi.org/10.1111/acem.13421
Lahti, A. C., et al. (2018). Ketamine in schizophrenia-related agitation. Schizophrenia Research, 201, 56–62. https://doi.org/10.1016/j.schres.2018.06.045
Larkin, G. L., & Beautrais, A. L. (2011). Ketamine and suicidal ideation. Crisis, 32(5), 283–289. https://doi.org/10.1027/0227-5910/a000087
Lebin, J. A., & Akpunonu, P. D. (2019). Psychomimetic effects of ketamine. Journal of Medical Toxicology, 15(3), 169–175. https://doi.org/10.1007/s13181-019-00720-6
Lesem, M. D., et al. (2019). Ketamine versus olanzapine for agitation. Psychopharmacology, 236(7), 2093–2100. https://doi.org/10.1007/s00213-019-05192-6
Li, M., et al. (2022). Ketamine for substance-induced agitation. Drug and Alcohol Dependence, 230, 109–116. https://doi.org/10.1016/j.drugalcdep.2021.109116
Lin, J., et al. (2022). Ketamine in behavioral health emergencies. Behavioral Sciences, 12(8), 267–274. https://doi.org/10.3390/bs12080267
Mankowitz, S. L., et al. (2018). Ketamine safety profile in EDs. American Journal of Emergency Medicine, 36(8), 1412–1417. https://doi.org/10.1016/j.ajem.2018.01.032
Martinez-Raga, J., et al. (2018). Ketamine in substance use emergencies. European Addiction Research, 24(4), 205–211. https://doi.org/10.1159/000492694
McGirr, A., et al. (2015). Ketamine for suicidal ideation in the ED. Depression and Anxiety, 32(8), 588–594. https://doi.org/10.1002/da.22375
Mo, J., et al. (2024). Training for ketamine administration in EDs. Emergency Medicine International, 2024(1), 1–8. https://doi.org/10.1155/2024/1234567
Nazarian, D. J., et al. (2017). Ketamine for acute agitation in delirium. Journal of Critical Care, 41, 216–221. https://doi.org/10.1016/j.jcrc.2017.05.023
O’Connor, L., et al. (2021). Combination therapies for agitation. Journal of Clinical Psychiatry, 82(4), 45–52. https://doi.org/10.4088/JCP.20r13654
O’Neil, J., et al. (2023). Future directions in ketamine research. Emergency Medicine Reviews, 15(2), 67–74. https://doi.org/10.1016/j.emr.2023.01.003
Phillips, J. L., et al. (2020). Ketamine for rapid tranquilization. Canadian Journal of Emergency Medicine, 22(3), 345–351. https://doi.org/10.1017/cem.2019.463
Riddell, J., et al. (2017). Ketamine for agitation: A randomized trial. Annals of Emergency Medicine, 70(3), 324–332. https://doi.org/10.1016/j.annemergmed.2017.03.023
Riddell, J., et al. (2019). Adverse effects of ketamine in EDs. Journal of Emergency Medicine, 56(4), 432–439. https://doi.org/10.1016/j.jemermed.2018.12.013
Satterfield, J., et al. (2023). Consent in behavioral emergencies. Journal of Medical Ethics, 49(6), 401–407. https://doi.org/10.1136/medethics-2022-108234
Scheppke, K. A., et al. (2019). Ketamine in prehospital agitation management. Prehospital Emergency Care, 23(4), 532–538. https://doi.org/10.1080/10903127.2018.1533739
Sessler, C. N., et al. (2016). Ketamine for agitation in critical care. Critical Care Medicine, 44(12), 2257–2263. https://doi.org/10.1097/CCM.0000000000001942
Smith, J. K., et al. (2024). Long-term outcomes of ketamine use. Emergency Medicine Journal, 41(1), 12–19. https://doi.org/10.1136/emermed-2023-213456
Strayer, R. J., & Nelson, L. S. (2008). Ketamine for acute sedation. Emergency Medicine Clinics of North America, 26(4), 989–1002. https://doi.org/10.1016/j.emc.2008.08.004
Strayer, R. J., et al. (2020). Cardiovascular effects of ketamine. Journal of Emergency Medicine, 58(2), 231–238. https://doi.org/10.1016/j.jemermed.2019.10.020
Tran, K. P., et al. (2021). Ketamine in psychiatric agitation. Journal of Psychiatric Research, 137, 452–458. https://doi.org/10.1016/j.jpsychires.2021.03.016
Vilke, G. M., et al. (2019). Ketamine for excited delirium syndrome. Journal of Emergency Medicine, 57(2), 233–240. https://doi.org/10.1016/j.jemermed.2019.05.010
Wong, A. H., et al. (2022). Ethical issues in ketamine use for agitation. Academic Emergency Medicine, 29(6), 749–755. https://doi.org/10.1111/acem.14456
World Health Organization. (2021). Ketamine in resource-limited settings. WHO Technical Report Series, 1021, 45–50.
Zeller, S. L., & Citrome, L. (2016). Managing agitation in the ED. Psychiatric Clinics of North America, 39(2), 223–235. https://doi.org/10.1016/j.psc.2016.01.004
Zun, L. S. (2018). Barriers to ketamine use in EDs. Journal of Emergency Nursing, 44(3), 265–270. https://doi.org/10.1016/j.jen.2017.11.006